| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former 10% Owner | 10% Owner
3 companies
Column Group II, LP last filed a Form 4 in December 2024, as 10% Owner at RCUS. The filings on record cover 3 companies. From March 2018 to December 2024, the filings on record show 7 open-market purchases and 7 sales.
Our model assigns Column Group II, LP a strong insider score of 83/100, based on 14 past trades. Over a 12-month horizon, all 14 of those trades were profitable, with an average 12-month return of +34.6%.
At the last filing, the largest reported position was 470,427 shares of RCUS.
Shares as reported in the last Form 4 for each company; the most recent is from December 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2021 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Sell | 95,746 | $31.30 | $2,996,515.88 | -100% | +3.4% | -8.0% | |
| Sep 22, 2020 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Sell | 608,000 | $30.85 | $18,756,800.00 | -13.7% | - | - | |
| Aug 17, 2020 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Sell | 538,654 | $22.75 | $12,254,378.50 | -10.8% | - | - | |
| Nov 4, 2019 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Buy | 625,000 | $12.00 | $7,500,000.00 | +14.3% | - | - |